Latvija - latviešu - Zāļu valsts aģentūra

alcon bulgaria eood, bulgaria - dexamethasonum, neomycini sulphas, polymyxini b sulfas - acu pilieni, suspensija - 1 mg/3500 sv/6000 sv/ml

Latvija - latviešu - Zāļu valsts aģentūra

novartis pharmaceuticals uk limited, united kingdom - dexamethasonum, neomycini sulphas, polymyxini b sulfas - acu pilieni, suspensija - 1 mg/3500sv/6000 sv/ml

Latvija - latviešu - Zāļu valsts aģentūra

novartis s.r.o., czech republic - dexamethasonum, neomycini sulphas, polymyxini b sulfas - acu pilieni, suspensija - 1 mg/3500sv/6000 sv/ml

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

intervet international bv, nīderlande - tetracycline, neomycin, bacitracin, prednisolone - suspensija ievadīšanai tesmenī - laktējošas govis

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

laboratorios calier, s.a., spānija - toltrazurils - suspensija iekšķīgai lietošanai - 50 mg/ml - cūkas

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doksorubicīns - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Latvija - latviešu - Zāļu valsts aģentūra

medac gesellschaft für klinische spezialpräparate mbh, germany - mitomicīns - pulveris injekciju/infūziju šķīduma pagatavošanai vai intravezikāli lietojama šķīduma pagatavošanai - 1 mg/ml

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

intervet international b.v., nīderlande - bacitracīns,neomicīnu,prednizolons,tetraciklīnu hydrochloridum - suspensija ievadīšanai tesmenī - laktējošas govis

Latvija - latviešu - Zāļu valsts aģentūra

sopharma ad, bulgaria - gentamicīns - Šķīdums injekcijām/infūzijām - 40 mg/ml

Latvija - latviešu - Zāļu valsts aģentūra

sopharma ad, bulgaria - galantamīna hidrobromīds - Šķīdums injekcijām - 10 mg/ml